Results 181 to 190 of about 258,064 (337)

Proton Pump Inhibitors and Biomarkers of Haemostasis in Postmenopausal Women: The Buffalo OsteoPerio Study. [PDF]

Basic Clin Pharmacol Toxicol
Soliman AI, Wactawski-Wende J, Millen AE, Hovey KM, LaMonte MJ.   +4 more
europepmc   +1 more source

The cytochrome c oxidase of Paracoccus denitrificans pumps protons in a reconstituted system.

, 1982
Marc Solioz, Ernesto Carafoli, Bernd Ludwig   +2 more
openalex   +1 more source

CRISPR/Cas9‐Based Vanadium MXene‐Free Radical Spatiotemporally Controlled Nanoreactor for Photothermal‐Induced Multi‐Effect Synergistic Antitumor Therapy

Advanced Science, EarlyView.
In this study, a MXene‐based V4C3 nanoplatform, VARH, was constructed, which achieved a photothermal conversion efficiency of 44.21% in the NIR‐II window. This platform integrated photothermal therapy, chemodynamic therapy, and thermodynamic therapy with CRISPR/Cas9‐mediated heat shock protein 90 knock‐out technology.
Zi‐Jian Huang, Feng‐Ming Li, Yi‐Fan Tu, Ke‐Ke Feng, Cheng‐Lei Li, Shi‐Cheng Tian, Yong‐Shan Hu, Jing‐Wei Shao, Zhen‐Hua Liu   +8 more
wiley   +1 more source

Proton-pump inhibitors and palbociclib or abemaciclib in endocrine-sensitive breast cancer treatment. [PDF]

Sci Rep
Takada S, Takahashi K, Uozumi R, Mukohara T, Hayashida T, Iwabe M, Iihara H, Kusuhara-Mamishin K, Tahatsu K, Kitagawa Y, Tsuchiya M, Kitahora M, Umehara K, Nagayama A, Kosaka S, Asano-Niwa Y, Watanabe K, Seki T, Ohnuki K, Futamura M, Kawazoe H, Nakamura T.   +21 more
europepmc   +1 more source

Intervention by Post for Reducing the Chronic Use of High Doses of Proton Pump Inhibitors

, 2020
Elena Valverde Bilbao, Amaia Mendizabal Olaizola, Guillermo Delgado Alvarado, Itxaso Idoiaga Hoyos, Daniel Hernández Amunarriz   +4 more
openalex   +1 more source

OHP-067 Prescription Profile Analysis of Proton Pump Inhibitors in a Tertiary Hospital [PDF]

, 2013
A Díez Alcántara, V Saavedra Quirós, Elena Prieto, A Torralba Arranz   +3 more
openalex   +1 more source

Nanomedicine Meets Immunotherapy: Advancing Adoptive Cell Therapy with Nanoparticles in the Treatment of Cancer with Sustainability Perspectives

Advanced Science, EarlyView.
This review surveys nanoparticle‐based strategies to enhance adoptive cell therapy, particularly CAR‐T cell approaches, in solid tumor treatment. It describes how nanoparticles can improve tumor immunogenicity and T‐cell infiltration while reducing toxicity, and how they enable in vivo CAR‐T cell generation.
Erica Frostegård, Tatiana Bobrova, Amalie Leinebø, Thibault Leray, Shayamita Ghosh, Lorena García‐Hevia, Chiara Puccinelli, Lorenzo Riccio, Jacopo Sorani, Davide Bonifazi, Julien Caumartin, Emmanuel Donnadieu, Florence Gazeau, Roland Hischier, Else Marit Inderberg, Mónica L. Fanarraga, Maria Loustau, Bernd Nowack, Sébastien Wälchli, Cécilia Ménard‐Moyon   +19 more
wiley   +1 more source

The effect of the use of proton pump inhibitors (PPI) on complications in patients with cirrhosis. [PDF]

BMC Gastroenterol
Atasoy H, Levent A.
europepmc   +1 more source

Modelling and kinetics of light induced proton pumping of bacteriorhodopsin reconstituted liposomes

, 1991
İnci Eroğlu, Baker M. Zubat, Meral Yücel   +2 more
openalex   +2 more sources

Disease severity and proton pump inhibitor use impacts strongest on faecal microbiome composition in cirrhosis

, 2020
Vanessa Stadlbauer, Irina Komarova, Ingeborg Klymiuk, Marija Durdević, Alexander J. Reisinger, Andreas Blesl, Florian Rainer, Angela Horvath   +7 more
openalex   +1 more source